| Identification | Back Directory | [Name]
Parecoxib | [CAS]
198470-84-7 | [Synonyms]
Valus-P
Vorth-P
SC 69124
Parocoxib
Parecoxib (free)
Parecoxib USP/EP/BP
parecoxib free base
Parecoxib impurities
Valdecoxib Impurity J
Parecoxib SodiuM IMpurity W
Parecoxib Sodium Impurity 81
Parecoxib SodiuM iMpurity PR-12-I
Parecoxib (This product is unavailable in the U.S.)
N-[4-(5-methyl-3-phenyl-oxazol-4-yl)phenyl]sulfonylpropanamide
N-(4-(5-Methyl-3-phenylisoxazol-4-yl)phenylsulfonyl)propionaMide
N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide
Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-
N-((4-(5-Methyl-3-phenyl-2,3-dihydrooxazol-4-yl)phenyl)sulfonyl)propionaMide | [EINECS(EC#)]
803-261-6 | [Molecular Formula]
C19H18N2O4S | [MDL Number]
MFCD08141856 | [MOL File]
198470-84-7.mol | [Molecular Weight]
370.42 |
| Chemical Properties | Back Directory | [Melting point ]
148.9-151° | [density ]
1.264 | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
neat | [pka]
5.08±0.10(Predicted) | [color ]
White to off-white | [BRN ]
8640266 |
| Hazard Information | Back Directory | [Uses]
Anti-inflammatory; analgesic (cyclooxygenase COX-2 inhibitor). | [Definition]
ChEBI: An N-acylsulfonamide resulting from the formal condensation of valdecoxib with propionic acid. It is a prodrug for valdecoxib. |
|
|